InvestSMART

Oncosil Medical Limited (ASX: OSL) - Announcements

- Current share price for OSL : $0.810

ASX company news and announcements for Oncosil Medical Limited (OSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Oncosil Medical Limited (OSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Oncosil Medical Limited (OSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Oncosil Medical Limited (OSL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$25 Notification regarding unquoted securities - OSL 19 Jun 2025 10:30AM $1.045 $0.810 fallen by 22.49%
$25 Change in substantial holding from SOL 18 Jun 2025 3:37PM $1.015 $0.810 fallen by 20.20%
$25 Change in substantial holding from PCG 17 Jun 2025 3:27PM $0.940 $0.810 fallen by 13.83%
$25 Notice of Extraordinary General Meeting/Proxy Form 6 Jun 2025 8:25AM $1.050 $0.810 fallen by 22.86%
$25 Update - Consolidation/Split - OSL 6 Jun 2025 8:24AM $1.050 $0.810 fallen by 22.86%
$25 Capital Consolidation Complete 6 Jun 2025 8:24AM $1.050 $0.810 fallen by 22.86%
$25 Security Purchase Plan (SPP) Now Open 4 Jun 2025 10:05AM $0.950 $0.810 fallen by 14.74%
$25 Notice under section 708A 3 Jun 2025 10:11AM $0.003 $0.810 risen by 26,900%
$25 Application for quotation of securities - OSL 3 Jun 2025 10:06AM $0.003 $0.810 risen by 26,900%
$25 Update - Consolidation/Split - OSL 29 May 2025 1:40PM $0.003 $0.810 risen by 26,900%
$25 Results of Meeting 29 May 2025 11:07AM $0.003 $0.810 risen by 32,300%
$25 Proposed issue of securities - OSL 26 May 2025 11:07AM $0.003 $0.810 risen by 26,900%
$25 Proposed issue of securities - OSL 26 May 2025 10:44AM $0.003 $0.810 risen by 26,900%
$25 Proposed issue of securities - OSL 26 May 2025 10:33AM $0.004 $0.810 risen by 23,042.86%
$25 Investor Presentation 26 May 2025 10:27AM $0.004 $0.810 risen by 23,042.86%
$25 Prospectus 26 May 2025 10:23AM $0.004 $0.810 risen by 23,042.86%
$25 OSL announces $8.7m capital raise to drive commercialisation 26 May 2025 10:17AM $0.004 $0.810 risen by 23,042.86%
$25 Trading Halt 22 May 2025 8:34AM $0.004 $0.810 risen by 23,042.86%
$25 OncoSil Outperforms SBRT in Pancreatic Cancer Outcomes 7 May 2025 8:33AM $0.004 $0.810 risen by 20,150%
$25 Application for quotation of securities - OSL 5 May 2025 4:45PM $0.003 $0.810 risen by 26,900%
$25 Quarterly Activities/Appendix 4C Cash Flow Report Addendum 2 May 2025 5:25PM $0.004 $0.810 risen by 23,042.86%
$25 Update - Consolidation/Split - OSL 1 May 2025 5:05PM $0.004 $0.810 risen by 23,042.86%
$25 Consolidation/Split - OSL 1 May 2025 12:23PM $0.004 $0.810 risen by 20,150%
$25 Tender Process for CRO to Undertake G-BA Study Commences 30 Apr 2025 3:29PM $0.004 $0.810 risen by 20,150%
$25 Notice of Extraordinary General Meeting/Proxy Form 30 Apr 2025 10:15AM $0.005 $0.810 risen by 16,100%

126 - 150 of 782 results

Page 6 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.